CUSIP 45790W108COMQ2 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ2 2025
85 funds hold this security · Q2 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Beryl Capital Management LLC | 6.32M | $25.29M | +6.32M | New |
| 2 | Pivotal Bioventure Partners Investment Advisor LLC | 4.49M | $17.98M | 0 | Held |
| 3 | Sofinnova Investments, Inc. | 4.28M | $17.12M | 0 | Held |
| 4 | Oddo Bhf Asset Management Sas | 3.20M |
| $12.80M |
| +3.20M |
| New |
| 5 | Trium Capital LLP | 3.17M | $12.69M | +3.17M | New |
| 6 | Blackrock, Inc. | 2.66M | $10.65M | −1.08M | Reduced |
| 7 | Vanguard Group Inc | 2.50M | $9.99M | −259.8K | Reduced |
| 8 | Nea Management Company, LLC | 2.44M | $9.75M | 0 | Held |
| 9 | Alpine Associates Management Inc. | 2.19M | $8.75M | +2.19M | New |
| 10 | Affinity Asset Advisors, LLC | 1.75M | $7.00M | −2.12M | Reduced |
See every fund holding Inozyme Pharma Inc, with full quarter-over-quarter share changes.
Unlock all holders